Ensysce Biosciences (ENSCW) Total Liabilities (2017 - 2025)

Ensysce Biosciences (ENSCW) has 9 years of Total Liabilities data on file, last reported at $4.6 million in Q4 2025.

• Total Liabilities for Q4 2025 came in at $4.6 million, up 106.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.6 million (up 106.0% YoY), and the FY2025 annual result was $4.6 million, up 106.0% from the prior year.
• Total Liabilities grew to $4.6 million in Q4 2025 per ENSCW's latest filing, from $2.3 million in the prior quarter.
• Over five years, Total Liabilities peaked at $24.6 million in Q4 2021 and troughed at $1.3 million in Q2 2024.
• A 5-year average of $6.3 million and a median of $3.7 million in 2021 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2021 and 2023: Total Liabilities jumped 250.56% in 2021, then slumped 85.99% in 2023.
• A 5-year view of Total Liabilities shows it stood at $24.6 million in 2021, then sank by 59.66% to $9.9 million in 2022, then tumbled by 66.12% to $3.4 million in 2023, then plunged by 34.0% to $2.2 million in 2024, then soared by 106.0% to $4.6 million in 2025.
• Business Quant data shows ENSCW's Total Liabilities at $4.6 million in Q4 2025, $2.3 million in Q3 2025, and $2.5 million in Q2 2025.